Zomagen Biosciences

Technologiepark 82

9052 Zwijnaarde

BE

Zomagen Biosciences

Foundation date

26/02/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.

Upcoming events

Latest news

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Mithra announces Estelle® launch in Belgium

    Thursday October 21st 2021

  • Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes

    Wednesday October 20th 2021